Fever of unknown origin (FUO) is a common medical condition in which a patient has a fever that cannot be explained by a known cause. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. FUO can be a frustrating condition for both patients and medical professionals, as it can take a long time to diagnose and treat. In this article, we will explore the medical abbreviation FUO and discuss the various causes, diagnosis, and treatment of this condition.
FUO is a medical abbreviation for fever of unknown origin. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. FUO is defined as a fever that has persisted for more than three weeks without an identifiable cause. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. The condition is most common in elderly patients, but can occur in any age group. It is important to note that FUO is not a specific disease, but rather a diagnosis of exclusion. This means that the cause of the fever must be determined before a diagnosis of FUO can be made.
The exact cause of FUO is often unknown, but there are many potential causes. These include infections, autoimmune disorders, malignancies, and medications. Infections are the most common cause of FUO, with viral infections such as influenza, mononucleosis, and HIV being the most common. Bacterial infections, such as tuberculosis, can also cause FUO. Autoimmune disorders, such as lupus, can also cause FUO. Malignancies, such as lymphoma and leukemia, can also cause FUO. Finally, medications, such as certain antibiotics, can also cause FUO.
The diagnosis of FUO is often a long and frustrating process. It involves a thorough medical history and physical examination, as well as laboratory tests and imaging studies. The first step in diagnosing FUO is to rule out other causes of fever. This includes testing for infections, autoimmune disorders, malignancies, and medications. If these tests are negative, a diagnosis of FUO can be made. The next step in diagnosing FUO is to identify any underlying cause. This may involve further testing, such as additional laboratory tests, imaging studies, or biopsies. Once the underlying cause is identified, treatment can be tailored to the specific condition.
The treatment of FUO depends on the underlying cause. If an infection is the cause, antibiotics may be prescribed. If an autoimmune disorder is the cause, immunosuppressive medications may be prescribed. If a malignancy is the cause, chemotherapy may be prescribed. If a medication is the cause, the medication may be discontinued.
Fever of unknown origin (FUO) is a common medical condition in which a patient has a fever that cannot be explained by a known cause. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. The exact cause of FUO is often unknown, but there are many potential causes. The diagnosis of FUO involves a thorough medical history and physical examination, as well as laboratory tests and imaging studies. The treatment of FUO depends on the underlying cause. FUO can be a frustrating condition for both patients and medical professionals, but with proper diagnosis and treatment, it can be managed effectively.
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation